An Evaluation of Proton Beam Therapy Authors: Evaluation Subcommittee of ASTRO’s Emerging Technologies Committee

• This document was prepared by the Emerging Technology Committee of the American Society for Radiation Oncology. • Prior to initiation of this evaluation project, all members of the Emerging Technology Committee (ETC) and of the Task Group performing the evaluation, were required to complete Conflict of Interest statements. These statements are maintained at ASTRO Headquarters in Fairfax, Va., and any pertinent conflict information will be published with the report. Individuals with disqualifying conflicts are recused from participation in ASTRO emerging technology assessments. • The primary role of the ETC is to provide technology assessments regarding emerging technologies to various stakeholders within and outside the Society. It is not the role of the Committee to develop or defend code definitions, valuation recommendations or other payment policy development functions. • ASTRO Emerging Technology Reports present scientific, health and safety information and may to some extent reflect scientific or medical opinion. They are made available to ASTRO members and to the public for educational and informational purposes only. Any commercial use of any content in this report without the prior written consent of ASTRO is strictly prohibited. • ASTRO does not make or imply any warranties concerning the safety or clinical efficacy of the devices reviewed in this report. ASTRO assumes no liability for the information, conclusions, and findings contained in its Emerging Technology Reports. • ASTRO regards any consideration of its technology assessment reports to be voluntary, with the ultimate determination regarding any technology's application to be made by the practitioner, in consultation with the patient, in light of each patient's individual circumstances in accordance with applicable law. Decisions regarding coverage of a technology, device or procedure are made by payors and government